Pegcetacoplan
POT-CP121614
Phase 2 small_molecule completed
Quick answer
Pegcetacoplan for Geographic Atrophy is a Phase 2 program (small_molecule) at Apellis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Pharmaceuticals
- Indication
- Geographic Atrophy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed